Marketing analysis of influenza vaccines in Ukraine

Authors

DOI:

https://doi.org/10.24959/nphj.21.51

Keywords:

acute respiratory viral infections; vaccine; pharmaceutical market of Ukraine; marketing analysis

Abstract

Acute respiratory viral infections (ARVI) are highly prevalent, and it is especially dangerous during the COVID-19 pandemic. The most effective way to prevent the ARVI is vaccination.

Aim. To analyze the pharmaceutical market of vaccines registered in Ukraine.

Material and methods. The material of the study was data of the State Register of Medicines of Ukraine 2020, information on the results of the epidemic season of influenza and ARVI of the Center for Public Health of the Ministry of Health of Ukraine, declared wholesale prices for vaccines in Ukraine in December 2020. The methods of frequency
and descriptive analysis were used.

Results and discussion. As a result of the structural analysis of ATC classification it was found that viral vaccines against influenza of J07B В group were presented at the pharmaceutical market. The frequency analysis revealed that there were 665.000 doses of vaccines of 4 trade names at the pharmaceutical market of Ukraine in 2020, all of them were of foreign production from France, the Netherlands, Great Britain, Korea. Among the vaccines purchased, 75 % were French-made vaccines. The cost of one vaccine dose ranged from 185.00 to 249.69 UAH. It was found that the number of vaccine doses purchased for the population during the study period (2016-2020) increased in 190 times. The population vaccination increased from 106683 to 238079 people, i.e. by 123 %.

Conclusions. As a result of the research conducted it was found that in 2020-2021 there were 4 trade names of foreign vaccines at the pharmaceutical market of Ukraine. The cost of one dose of vaccines ranged from 185.00 tо 249.69 UAH.

Author Biographies

V. S. Zlahoda , National Pirogov Memorial Medical University, Vinnytsya

teaching assistant of the Department of Pharmacy

T. I. Ivko , National Pirogov Memorial Medical University, Vinnytsya

Candidate of Pharmacy (Ph.D), associate professor of the Department of Pharmacy

Т. А. Germanyuk , National Pirogov Memorial Medical University, Vinnytsya

Doctor of Medicine (Dr. habil.), professor of the Department of Pharmacy

L. O. Bobrytska, National University of Pharmacy of the Ministry of Health of Ukraine

Doctor of Pharmacy (Dr. habil.), professor of the Department of Industrial Technology of Drugs

References

Немченко А. С., Сімонян Л. С. Маркетинговий аналіз асортименту вакцин від грипу та показників їх доступності. Сучасні досягнення фармацевтичної технології : матеріали ІV наук.–практ. конф. з міжнар. участю, м. Харків, 16–17 жовт. 2014 р. Xарків : НФаУ, 2014. С. 211.

Немченко А. С., Сімонян Л. С, Немченко О. А. Дослідження цінових характеристик вакцин від вірусу грипу. Фармакоекономіка в Україні : стан та перспективи розвитку : матеріали VII наук.–практ. Internet–конф., м. Харків, 20 листоп. 2014 р. Харків : НФаУ, 2014. С. 83–84.

Глушко–Маківська А. П., Соколовська О. О. Сучасні тенденції впровадження вакцинації проти грипу. Інфекційні хвороби. 2015. № 4 (82). С. 101. DOI: https://doi.org/10.11603/1681-2727.2015.4.5531.

Оришака О. В., Марченко К. Н., Марченко А. К. Вакцинирование как составляющая безопасности жизнедеятельности во время пандемии SARS–CoV–2. Соціальна фармація в охороні здоров’я. 2021. Vol. 7, № 2. С. 27–33. DOI: https://doi.org/10.24959/sphhcj.21.226.

Вінницька обласна державна адміністрація. URL: http://www.vin.gov.ua/departament-okhorony-zdorovia/31057-prohrama-stophryp-startuvala.

Державний реєстр лікарських засобів. URL: http://www.drlz.com.ua/ibp/ddsite.nsf/all/shlist?opendocument.

Підсумки епідемічних сезонів грипу та гострих респіраторних інфекцій Центру громадського здоров’я МОЗ України. URL: https://bit.ly/2XpWZQP.

Дані державного реєстру оптово-відпускних цін станом на 01.12.2020 р. URL: https://pharmbase.com.ua/ru/optovye-predlozheniya

Downloads

Published

2021-10-19

Issue

No. 2(102) (2021)

Section

Organization and Economy of Pharmacy

License

Copyright (c) 2021 National University of Pharmacy

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).